Roche: FDA designation for blood test
Developed in collaboration with Amgen, this Roche Diagnostics test measures Lp(a) in a person's bloodstream and will be available on the installed base of more than 90.000 serum working area (SWA) systems worldwide.
'Approximately one in five people worldwide has high levels of Lp(a), putting them at increased risk of cardiovascular disease, including myocardial infarction and stroke', stresses the Swiss healthcare group.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction